Iscaffpharma Highlights Technology & Innovation AveNEW Opportunity

from New Matter: Inside the Minds of SLAS Scientists · host SLAS

Iscaffpharma CEO Per Setterberg shares how they are focusing on developing better treatments of aggressive cancers by providing 3D scaffolds mimicking human tumour environment as a platform for research and development.Upcoming Events:SLAS Meet-UpsLeiden, Netherlands (10 September 2026)Tübingen, Germany (20 October 2026)SLAS 2026 Sample Management Symposium (October 21-22, 2026 | South San Francisco, California)SLAS2027 International Conference & Exhibition (January 30 - February 3, 2027 | San Diego, California)View the full events calendar

Episode metadata supplied by the publisher feed · Published Apr 11, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Iscaffpharma Highlights Technology & Innovation AveNEW Opportunity

0:00 7:38

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of New Matter: Inside the Minds of SLAS Scientists?

This episode is 7 minutes long.

When was this New Matter: Inside the Minds of SLAS Scientists episode published?

This episode was published on April 11, 2020.

Can I download this New Matter: Inside the Minds of SLAS Scientists episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!